Investment
Features
FeesSafety
Academy
More
Pluang+

Graphene Manufacturing Group expands sales team in Asia Pacific to boost growth in key markets.

Market News
08 Sep 2026
Proactive Investors
View Source
Bullish
Graphene Manufacturing Group expands sales team in Asia Pacific to boost growth in key markets.

Graphene Manufacturing Group Ltd has launched a dedicated sales team for the Asia Pacific region, targeting India, South Korea, Japan, and Singapore, in addition to its existing operations in Australia. This expansion supports the company's global commercialization strategy by tapping into major manufacturing, automotive, electronics, and data-center industries in these fast-growing markets. The move follows recent production milestones, including the start-up of their Gen 2.0 graphene plant, and aims to strengthen GMG's presence in thermal management, lubricants, and energy storage sectors. The company is encouraged by early customer interest and views this regional build-out as a logical step in its international growth plan.

More News

Opus Genetics gets Buy rating ahead of key gene therapy data release on Sept 9, 2026.

Opus Genetics gets Buy rating ahead of key gene therapy data release on Sept 9, 2026.

Opus Genetics, a clinical-stage biotech focused on inherited retinal diseases, received a Buy rating and $8 price target from analyst Matthew Caufield in August 2026. The company plans to release topline Phase 1/2 data for its gene therapy OPGx-BEST1...

Analyst Insights
Bullish
56 minutes ago
GE to acquire CPP for $11.75B, boosting aerospace casting capacity and earnings potential

GE to acquire CPP for $11.75B, boosting aerospace casting capacity and earnings potential

General Electric (GE) announced it will acquire Consolidated Precision Products (CPP) for $11.75 billion to enhance its aerospace casting production. This strategic move aims to strengthen GE's manufacturing capabilities and accelerate engine technol...

Analyst Insights
Bullish
59 minutes ago
UNFI beats Q4 EPS estimates but misses revenue, expects growth ahead.

UNFI beats Q4 EPS estimates but misses revenue, expects growth ahead.

United Natural Foods, Inc. (UNFI) reported a Q4 adjusted EPS of $0.69, surpassing analyst expectations of $0.61, signaling strong profitability. However, revenue slightly missed estimates at $7.64 billion, down 0.7% from the previous year. Despite th...

Company Fundamentals
Bullish
1 hour ago
Ionis Pharmaceuticals gets $85 price target despite heart drug trial failure

Ionis Pharmaceuticals gets $85 price target despite heart drug trial failure

Ionis Pharmaceuticals faced a setback when its experimental heart drug pelacarsen failed a Phase 3 trial to reduce cardiovascular events, causing an 8.6% stock drop. However, an analyst from Canaccord Genuity maintained a bullish $85 price target, im...

Analyst Insights
Bullish
2 hours ago
Casey's General Stores to report Q3 earnings with strong analyst expectations on Sept 8, 2026.

Casey's General Stores to report Q3 earnings with strong analyst expectations on Sept 8, 2026.

Casey's General Stores will release its Q3 2026 earnings on September 8 after market close, with analysts expecting an EPS of $6.78 and revenue of $5.56 billion. The company has a strong history of exceeding earnings estimates, with an average surpri...

Company Fundamentals
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App